Cargando…

Acquired hemophilia A: emerging treatment options

Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor) to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe, potentially life-threatening hemorrhage. Disease management focuses on controlling bleeding, primarily with the use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janbain, Maissaa, Leissinger, Cindy A, Kruse-Jarres, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431493/ https://www.ncbi.nlm.nih.gov/pubmed/26056504 http://dx.doi.org/10.2147/JBM.S77332

Ejemplares similares

2285: Analysis of racial disparity in the whole blood and plasma of healthy volunteers using rotational thromboelastometry
por: Janbain, Maissaa, et al.
Publicado: (2018)

Managing Pregnant Women with Hemophilia and von Willebrand Disease: How Do We Provide Optimum Care and Prevent Complications?
por: Janbain, Maissaa, et al.
Publicado: (2022)

Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
por: Escobar, Miguel A., et al.
Publicado: (2022)

Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence
por: Dargaud, Yesim, et al.
Publicado: (2021)

Balance, falls, and exercise: Beliefs and experiences in people with hemophilia: A qualitative study
por: Flaherty, Lorraine M., et al.
Publicado: (2017)

Acquired Hemophilia A: An Update on the Etiopathogenesis, Diagnosis, and Treatment
por: Zanon, Ezio
Publicado: (2023)

The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study
por: Barnes, Richard F. W., et al.
Publicado: (2016)

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database
por: Peyvandi, Flora, et al.
Publicado: (2020)

Acquired Hemophilia
por: Özsoylu, Şinasi
Publicado: (2014)

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
por: Elverdi, Tugrul, et al.
Publicado: (2019)

Managing Severe Hemophilia A in Children: Pharmacotherapeutic Options
por: Regling, Katherine, et al.
Publicado: (2022)

The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors
por: Meeks, Shannon L., et al.
Publicado: (2019)

Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia A
por: Sanabria, Martin, et al.
Publicado: (2021)

A Case of Acquired Hemophilia A and Congenital Hemophilia B
por: Fortier, Julia C, et al.
Publicado: (2022)

B cell–activating factor modulates the factor VIII immune response in hemophilia A
por: Doshi, Bhavya S., et al.
Publicado: (2021)

New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand Syndrome
por: Leebeek, Frank W. G.
Publicado: (2021)

Principles of care for acquired hemophilia
por: Dolan, Gerry, et al.
Publicado: (2021)

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
por: Collins, Peter, et al.
Publicado: (2010)

International recommendations on the diagnosis and treatment of acquired hemophilia A
por: Tiede, Andreas, et al.
Publicado: (2020)

Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies
por: Marino, Renato
Publicado: (2023)

The Treatment of Acquired Hemophilia with Combination Therapy of Immunosuppressives and Immunoadsorption
por: Uğur Bilgin, Aynur, et al.
Publicado: (2014)

Emerging and future therapies for hemophilia
por: Carr, Marcus E, et al.
Publicado: (2015)

Acquired Hemophilia A with Gastrointestinal Bleeding
por: Park, Narae, et al.
Publicado: (2020)

Acquired Hemophilia A and urothelial carcinoma
por: Taza, Fadi, et al.
Publicado: (2021)

The role of point-of-Care Musculoskeletal Ultrasound for Routine Joint evaluation and management in the Hemophilia Clinic - A Real World Experience
por: Gallastegui, N, et al.
Publicado: (2022)

Acquired hemophilia A (AHA): underreported, underdiagnosed, undertreated medical condition
por: El Demerdash, Doaa M., et al.
Publicado: (2022)

Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice
por: Pishko, Allyson M, et al.
Publicado: (2022)

Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database
por: Pipe, Steven W., et al.
Publicado: (2020)

Developments in the treatment of hemophilia B: focus on emerging gene therapy
por: Cancio, Maria I, et al.
Publicado: (2013)

Treatment adherence in hemophilia
por: Thornburg, Courtney D, et al.
Publicado: (2017)

Acquired Hemophilia A Successfully Treated with Rituximab
por: D’Arena, Giovanni, et al.
Publicado: (2015)

Management of Acquired Hemophilia A in Elderly Patients
por: Yamaguchi, Tomoya, et al.
Publicado: (2018)

Acquired Hemophilia A Presenting as Intramuscular Hematoma
por: Al-Shbool, Ghassan, et al.
Publicado: (2018)

Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A
por: Jayasundara, Hishali D, et al.
Publicado: (2021)

An Unusual Case of Bleeding: Acquired Hemophilia A
por: Jahangiri, Omeed S, et al.
Publicado: (2023)

Acquired Hemophilia A: A Rare, Acquired Coagulopathy in the Postpartum Setting
por: Oberlin, Austin, et al.
Publicado: (2023)

Acquired Hemophilia A: A Frequently Overlooked Autoimmune Hemorrhagic Disorder
por: Sakurai, Yoshihiko, et al.
Publicado: (2014)

Emicizumab Use in Treatment of Acquired Hemophilia A: A Case Report
por: Al-Banaa, Kadhim, et al.
Publicado: (2019)

Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient’s Perspectives
por: Pasca, Samantha
Publicado: (2022)

Emerging therapies for hemophilia: controversies and unanswered questions
por: Arruda, Valder R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6dmkok873gdgfkkk563niu3vl6